Effectiveness and safety of acupotomy on lumbar spinal stenosis: A pragmatic randomized, controlled, pilot clinical trial: A study protocol

• Published in: Medicine (Baltimore) Vol. 100; no. 51; p. e28175
• Main Authors: Han, Ji Hoon, Lee, Hyun-Jong, Woo, Sang Ha, Park, Yu-Kyeong, Choi, Ga-Young, Heo, Eun Sil, Kim, Jae Soo, Lee, Jung Hee, Park, Chung A, Lee, Woo Dong, Yang, Chang Sop, Kim, Ae-Ran, Han, Chang-Hyun
• Format: Journal Article
• Language: English
• Published: United States Lippincott Williams & Wilkins 23.12.2021
• Subjects: Acupuncture Therapy - adverse effects; Acupuncture Therapy - methods; Humans; Pain Measurement; Pragmatic Clinical Trials as Topic; Randomized Controlled Trials as Topic; Spinal Stenosis - therapy; Study Protocol Clinical Trial; Treatment Outcome
• ISSN: 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000028175

Lumbar spinal stenosis (LSS) is a pathological condition that causes a variety of neurological symptoms due to narrowing of the anatomical structures; usually, conservative treatment is recommended, rather than surgical treatment. Acupotomy combines conventional acupuncture with small scalpels; the procedure can be considered minimally invasive, and has recently received considerable attention in clinical practice. Still, there is a lack of data and randomized controlled trials regarding acupotomy related to LSS. Additional studies are necessary, considering the low methodological quality and small size of the study. This is a pragmatic, pilot, randomized controlled trial. The trial comprises 8 weeks of treatment, with 16 visits and a 4-week follow-up period. Forty participants diagnosed with LSS will be randomly assigned to either the experimental or control groups; both groups will receive acupuncture and interferential current therapy twice a week for 8 weeks, while the experimental group will receive an additional acupotomy intervention once a week for 8 weeks. The primary outcome will be assessed using the visual analog scale; the secondary outcome will be measured by self-rated walking distance, Oswestry Disability Index, and short-form McGill Pain Questionnaire. Measurements will be obtained prior to the start of the clinical trial, 4 weeks after the interventional procedure, 8 weeks after the procedure, and 4 weeks after the end of the interventional procedure. Blood tests and adverse reactions will be performed to ensure safety of the treatments. We expect that this study will provide basic data for future large-scale acupotomy studies regarding LSS.